Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Auli Ropo
Observed names:
A ROPO,
A Ropo,
A. Ropo,
AULI ROPO,
Ropo, Auli
Observed institutions:
University of Helsinki,
Santen (Japan),
University of Turku,
Tampere University,
Helsinki University Hospital,
Santen (Finland),
Tampere University Hospital,
University of Tampere
show all 8
ORCID:
0009-0009-5603-9020
Observed ORCID:
0009-0009-5603-9020
OpenAlex ID:
A5000825873
Switching from a preserved to a preservative‐free prostaglandin preparation in topical glaucoma medication
2010
·
Hannu Uusitalo
, Enping Chen
, et al.
·
Acta Ophthalmologica
·
165
PDF
Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open‐angle glaucoma and ocular hypertension: 24‐month results of a randomized, double‐masked phase III study
2010
·
Hannu Uusitalo
, Lutz E Pillunat
, et al.
·
Acta Ophthalmologica
·
111
PDF
Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effects
2006
·
T. Nieminen
, T. Lehtimäki
, et al.
·
Scandinavian Journal of Clinical and Laboratory Investigation
·
95
Efficacy and safety levels of preserved and preservative‐free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis
2008
·
Thomas Hamacher
, Juhani Airaksinen
, et al.
·
Acta Ophthalmologica
·
82
PDF
Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
2016
·
Hannu Uusitalo
, Evgeniy Egorov
, et al.
·
Clinical ophthalmology
·
72
PDF
Pharmacokinetics, efficacy and safety profiles of preserved and preservative‐free tafluprost in healthy volunteers
2008
·
Hannu Uusitalo
, Kai Kaarniranta
, et al.
·
Acta Ophthalmologica
·
57
PDF
Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
2020
·
Makoto Aihara
, Auli Ropo
, et al.
·
Japanese Journal of Ophthalmology
·
56
Efficacy and systemic side‐effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel
2005
·
Hannu Uusitalo
, Juanita Niño
, et al.
·
Acta Ophthalmologica Scandinavica
·
56
PDF
Efficacy, Safety, and Tolerability of Preservative-Free Fixed Combination of Tafluprost 0.0015%/Timolol 0.5% Versus Concomitant Use of the Ingredients
2014
·
Gábor Holló
, Anton Hommer
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
53
A Phase II Study on the Duration and Stability of the Intraocular Pressure-Lowering Effect and Tolerability of Tafluprost Compared With Latanoprost
2010
·
Carlo E. Traverso
, Auli Ropo
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
51
Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study
2005
·
Tuomo Nieminen
, Hannu Uusitalo
, et al.
·
European Journal of Clinical Pharmacology
·
51
Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products
2014
·
Gábor Holló
, Jouni Vuorinen
, et al.
·
Advances in Therapy
·
47
PDF
A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
2014
·
Norbert Pfeiffer
, Carlo E. Traverso
, et al.
·
Advances in Therapy
·
46
PDF
A Comparative, Placebo-Controlled Study of Prostanoid Fluoroprostaglandin-Receptor Agonists Tafluprost and Latanoprost in Healthy Males
2007
·
Andrew Sutton
, Anne Gilvarry
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
45
Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma
2006
·
Hannu Uusitalo
, Mika Kähönen
, et al.
·
Graefe s Archive for Clinical and Experimental Ophthalmology
·
45
Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops
2005
·
Hans-Reinhard Koch
, Sven C. Kulus
, et al.
·
Journal of Cataract & Refractive Surgery
·
44
Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients
2005
·
Tuomo Nieminen
, Hannu Uusitalo
, et al.
·
European Journal of Clinical Pharmacology
·
44
Comparison of retrobulbar and periocular injections of lignocaine by computerised tomography.
1991
·
A. Ropo
, P. Nikki
, et al.
·
British Journal of Ophthalmology
·
44
PDF
Visual evoked potentials after retrobulbar or periocular anaesthesia.
1992
·
A Ropo
, P Ruusuvaara
, et al.
·
British Journal of Ophthalmology
·
32
PDF
Ptosis following periocular or general anaesthesia in cataract surgery
1992
·
A. Ropo
, P. Ruusuvaara
, et al.
·
Acta Ophthalmologica
·
32
Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study
2019
·
Rupert Richard Alexander Bourne
, Kai Kaarniranta
, et al.
·
BMJ Open
·
31
PDF
Tafluprost, a new potent prostanoid receptor agonist: a dose-response study on pharmacodynamics and tolerability in healthy volunteers
2008
·
A. Sutton
, P. Gouws
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
29
Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin
2003
·
Joseph Colin
, Sylvie Simonpoli
, et al.
·
Acta Ophthalmologica Scandinavica
·
29
Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor
2008
·
Marjo Volotinen
, Jukka Mäenpää
, et al.
·
European Journal of Pharmaceutical Sciences
·
28
Handling Test of Eye Drop Dispenser—Comparison of Unit-Dose Pipettes with Conventional Eye Drop Bottles
2010
·
Minna Parkkari
, Terho Latvala
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
26
Show more works
View as search
Works count:
53
Citation count:
1,589
H-index:
26
I10-index:
35
Year
Topic
Type
